GGrantIndex
Sort

50,496 grants matching lung cancer

Project 3: Arsenic Biomarker Epidemiology

$413,232
Allan H Smith · University Of California Berkeley · P42 · FY2007 · ES

Project 2: Inhibiting AXL to Improve Treatment Response in Endometrial Cancer

$413,218
David G Mutch · Washington University · P50 · FY2024 · CA

Becton Dickinson LSR II Analytical Flow Cytometer

$413,206
Raphael A Clynes · Columbia University Health Sciences · S10 · FY2011 · RR

Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy

$413,191
Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2024 · CA

Descriptive Studies and Record Linkage

$413,182
Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA

Exploiting KRAS addiction for lung cancer therapy

$413,109
David A Cheresh · University Of California, San Diego · R01 · FY2018 · CA

Inhibition of Senescence to Increase Cancer Cell Death: A New Paradigm

$413,086
Hayley M. McDaid · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA

Community Clinical Oncology Program

$413,073
David L Grinblatt · Northshore University Healthsystem · U10 · FY2007 · CA

Purchase of a Triple Quadrupole Mass Spectrometer for Multiple Reaction Monitorin

$413,070
Robert J. Cotter · Johns Hopkins University · S10 · FY2009 · RR

FLT PET to Plan the Best Therapy for Lung Cancer

$413,058
Hubert J Vesselle · University Of Washington · R01 · FY2007 · CA

COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE

$413,032
Mansoor M. Amiji · Northeastern University · U01 · FY2011 · CA

COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE

$413,032
Mansoor M. Amiji · Northeastern University · U01 · FY2012 · CA

FLT PET to Plan the Best Therapy for Lung Cancer

$413,004
Hubert J Vesselle · University Of Washington · R01 · FY2006 · CA

SCH: INT: Collaborative Research: Crowd in Action: Human-Centric Privacy-Preserving Data Analytics for Environmental Public Health

$413,000
Yuguang Fang · University Of Florida · · FY2017 · CSE

FLT PET to Plan the Best Therapy for Lung Cancer

$412,936
Hubert J Vesselle · University Of Washington · R01 · FY2008 · CA

Adenovirus-host interactions and in vivo virus targeting

$412,933
Dmitry Shayakhmetov · University Of Washington · R01 · FY2012 · CA

High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader

$412,895
Xiaobing Shi · Van Andel Research Institute · R01 · FY2024 · CA

METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS

$412,892
Johns Hopkins University · R01 · FY2001 · CA

Molecular Drivers of Vascular Stiffness and Metabolic Dysfunction in HIV-Induced Pulmonary Arterial Hypertension

$412,816
Stephen Y Chan · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL

Unbiased electrothermal flow-enhanced identification of antigen-specific T cells in lung cancer

$412,768
Alexandre Reuben · University Of Tx Md Anderson Can Ctr · R21 · FY2023 · CA

Role of Reactive Oxygen Species in Lymphocyte Development and Function

$412,732
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

DEVELOPMENT OF NOVEL NONAGONIST PPAR-GAMMA LIGANDS FOR LUNG CANCER TREATMENT

$412,703
The General Hospital Corporation · · FY2015 · Department of the Army

Mitochondrial Degeneration – the Root of Skeletal Muscle Atrophy

$412,668
Nicholas Perry Greene · University Of Arkansas At Fayetteville · R15 · FY2017 · AR

Analysis of the Role of Microenvironment and Stem Cells in Initiation, Progressio

$412,645
Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2008 · CA

Role of T regulatory suppression in autoimmunity and cancer

$412,601
Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA